title: [Lymphomatoid papulosis in childhood: six case reports and a literature review].
abstract: BACKGROUND
  Lymphomatoid papulosis (LyP) is a rare lymphoproliferative disorder. It is now included in the World Health Organisation (WHO) classification of cutaneous lymphomas. Although frequently described in adults, there have been only a few reported cases of LyP in children; diagnosis is often difficult in this population and no clear guidelines have been established regarding management or monitoring. In this article we report six new cases of LyP in children.
  
  
  METHODS
  This is a retrospective study of six children, aged between two and 11 years, seen at the Hôtel-Dieu Hospital in Lyon and at the Grenoble Hospital Centre between 2005 and 2008. Each child underwent skin biopsy for histological and immunohistochemical analysis.
  
  
  RESULTS
  All six children presented papulonodular lesions on the limbs and trunk, in some cases necrotic, present for different times and developing in episodes. Histology and immunolabelling announces in all six cases militated in favour of LyP type A, with large CD30+ and CD15- cells dispersed in an inflammatory dermal infiltrate made up for the most part of lymphocytes, polynuclear neutrophils, eosinophils and a small number of histiocytes.
  
  
  CONCLUSIONS
  Only around 60 cases of LyP have so far been reported in children, principally type A. Association with malignant lymphoma occurs, with high risk in relation to the general population of the same age. Clinical diagnosis is confirmed histopathology and immunolabelling. There is currently no consensus regarding therapeutic management. First-line treatment generally comprises therapeutic abstention or dermal corticosteroids. Methotrexate and phototherapy constitute possible alternatives but should be used only in very disseminate or debilitating forms of the disease.
  
  
  CONCLUSIONS
  The presentation and course of LyP of childhood differs very little from the adult form. Cases of associated lymphoma have been reported. Although regular clinical monitoring is recommended, there is no call for routine laboratory testing.
authors.affiliation: Service de dermatologie, hôpital Hôtel-Dieu, 1 place de l'Hôpital, Lyon cedex 02, France.
authors.forename: N
authors.initials: N
authors.lastname: Bories
authors.forename: L
authors.initials: L
authors.lastname: Thomas
authors.forename: A
authors.initials: A
authors.lastname: Phan
authors.forename: B
authors.initials: B
authors.lastname: Balme
authors.forename: D
authors.initials: D
authors.lastname: Salameire
authors.forename: C
authors.initials: C
authors.lastname: Thurot-Guillou
authors.forename: S
authors.initials: S
authors.lastname: Dalle
mesh_terms: D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D017731:Lymphomatoid Papulosis / Q000473:pathology*; D008297:Male; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000473:pathology*